Intranuclear localization of human papillomavirus 16 E7 during transformation and preferential binding of E7 to the Rb family member p130.

Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco CA 94115, USA.
Proceedings of the National Academy of Sciences (Impact Factor: 9.81). 07/1999; 96(12):6999-7004. DOI: 10.1073/pnas.96.12.6999
Source: PubMed

ABSTRACT To study intracellular pathways by which the human papillomavirus 16 oncogene E7 participates in carcinogenesis, we expressed an inducible chimera of E7 by fusion to the hormone-binding domain of the estrogen receptor. The chimeric protein (E7ER) transformed rodent fibroblast cell lines and induced DNA synthesis on addition of estradiol. In coimmunoprecipitation experiments, E7ER preferentially bound p130 when compared to p107 and pRb. After estradiol addition, E7ER localization changed to a more intense intranuclear staining. Induction of E7 function was not correlated with binding to p130 or pRb but rather with intranuclear localization and modest induction of binding to p107.

  • [Show abstract] [Hide abstract]
    ABSTRACT: E7 is an accessory protein that is not encoded by all papillomaviruses. The E7 amino terminus contains two regions of similarity to conserved regions 1 and 2 of the adenovirus E1A protein, which are also conserved in the simian vacuolating virus 40 large tumor antigen. The E7 carboxyl terminus consists of a zinc-binding motif, which is related to similar motifs in E6 proteins. E7 proteins play a central role in the human papillomavirus life cycle, reprogramming the cellular environment to be conducive to viral replication. E7 proteins encoded by the cancer-associated alpha human papillomaviruses have potent transforming activities, which together with E6, are necessary but not sufficient to render their host squamous epithelial cell tumorigenic. This article strives to provide a comprehensive summary of the published research studies on human papillomavirus E7 proteins.
    Virology 05/2013; · 3.28 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The p53 tumor suppressor protein, one of the most extensively studied proteins, plays a pivotal role in cellular checkpoints that respond to DNA damage to prevent tumorigenesis. However, the transcriptional control of the p53 gene has not been fully characterized. We report that the transcription factor E2F1 binds only to the E2F1 distal site of the p53 promoter in the human papillomavirus positive carcinoma HeLa cell line. Moreover, we showed that etoposide, a DNA damaging agent, activates p53 transcription through the E2F1 pathway. This increase correlates with apoptosis induction as disruption of this pathway led to reduced apoptosis stimulation by the DNA damaging agent.
    FEBS letters 08/2013; · 3.54 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Viruses are potent oncogenic agents and are considered to link to approximately one-fifth of all human malignancies. The study of tumor viruses has provided fundamental bases of how normal cells become cancer cells. A number of virus-encoded oncogenes have been identified and their functions were characterized. One of the striking functional similarities of such virus oncogenes, especially the ones encoded by DNA tumor viruses, is that they bind to and inactivate tumor suppressor genes, such as p53 and pRb. In this chapter, I am going to summarize the function of virus oncogenes focusing on their interactions with p53.
    01/1970: pages 160-177;

Full-text (2 Sources)

Available from
May 27, 2014